SpinX
Geneva, Geneve, Switzerland
About SpinX
SpinX develops and commercializes a programmable lab-on-a-chip platform for applications that ranges from drug discovery to consumer diagnostics. Its products include SpinX Lab, a system to transition from low volume microplate assays to an automated bench-top technology for assays in nanoliter volumes; and workflow, an assay preparation for a panel of enzymatic assays. Bart Van de Vyver and Piero Zucchelli founded SpinX in 2003. It has its headquarters in Geneva in Switzerland.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $14.5M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Jan 2009)
- Website: spinx-technologies.com
- Phone: 41 22 719 09 00
Industries & Categories
Biotechnology, Health Diagnostics, Life Science, Medical Device, Robotics
Social Profiles
Canonical: https://fsome.com/organization/spinx-2591915 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.